Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,424
archived clinical trials in
Cognitive Studies

The SOMNUS Study: Sedative Optimization Via Monitoring Neurological Status
A Randomized Control Trial Using the BIS Monitor to Avoid Over Sedation and Prolonged Neuropsychological Deficits in Mechanically Ventilated ICU Patients
Status: Enrolling
Updated:  3/6/2018
Vanderbilt University Medical Center
mi
from
Nashville, TN
The SOMNUS Study: Sedative Optimization Via Monitoring Neurological Status
A Randomized Control Trial Using the BIS Monitor to Avoid Over Sedation and Prolonged Neuropsychological Deficits in Mechanically Ventilated ICU Patients
Status: Enrolling
Updated: 3/6/2018
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Effects of Alpha-lactalbumin Intake on Metabolic and Cognitive Functions in Elderly
Effects of Alpha-lactalbumin on Metabolic and Cognitive Functions in Healthy Older Adults
Status: Enrolling
Updated:  3/7/2018
Texas A&M University
mi
from
College Station, TX
Effects of Alpha-lactalbumin Intake on Metabolic and Cognitive Functions in Elderly
Effects of Alpha-lactalbumin on Metabolic and Cognitive Functions in Healthy Older Adults
Status: Enrolling
Updated: 3/7/2018
Texas A&M University
mi
from
College Station, TX
Click here to add this to my saved trials
Targeting Circadian and Cognitive Dysfunction in Bipolar Disorder With Modafinil
Targeting Circadian and Cognitive Dysfunction in Bipolar Disorder With Modafinil
Status: Enrolling
Updated:  3/20/2018
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
Targeting Circadian and Cognitive Dysfunction in Bipolar Disorder With Modafinil
Targeting Circadian and Cognitive Dysfunction in Bipolar Disorder With Modafinil
Status: Enrolling
Updated: 3/20/2018
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
Click here to add this to my saved trials
Video-Enhanced Care Management for Medically Complex Veterans
Video-Enhanced Care Management for Medically Complex Veterans
Status: Enrolling
Updated:  3/20/2018
Durham VA Medical Center, Durham, NC
mi
from
Durham, NC
Video-Enhanced Care Management for Medically Complex Veterans
Video-Enhanced Care Management for Medically Complex Veterans
Status: Enrolling
Updated: 3/20/2018
Durham VA Medical Center, Durham, NC
mi
from
Durham, NC
Click here to add this to my saved trials
Perioperative Cognitive Function - Dexmedetomidine and Cognitive Reserve
Perioperative Cognitive Function - Dexmedetomidine and Cognitive Reserve
Status: Enrolling
Updated:  3/22/2018
University of Miami Medical Center
mi
from
Miami, FL
Perioperative Cognitive Function - Dexmedetomidine and Cognitive Reserve
Perioperative Cognitive Function - Dexmedetomidine and Cognitive Reserve
Status: Enrolling
Updated: 3/22/2018
University of Miami Medical Center
mi
from
Miami, FL
Click here to add this to my saved trials
Perioperative Cognitive Function - Dexmedetomidine and Cognitive Reserve
Perioperative Cognitive Function - Dexmedetomidine and Cognitive Reserve
Status: Enrolling
Updated:  3/22/2018
Johns Hopkins Bayview Medical Center
mi
from
Baltimore, MD
Perioperative Cognitive Function - Dexmedetomidine and Cognitive Reserve
Perioperative Cognitive Function - Dexmedetomidine and Cognitive Reserve
Status: Enrolling
Updated: 3/22/2018
Johns Hopkins Bayview Medical Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Perioperative Cognitive Function - Dexmedetomidine and Cognitive Reserve
Perioperative Cognitive Function - Dexmedetomidine and Cognitive Reserve
Status: Enrolling
Updated:  3/22/2018
Englewood Hospital and Medical Center
mi
from
Englewood, NJ
Perioperative Cognitive Function - Dexmedetomidine and Cognitive Reserve
Perioperative Cognitive Function - Dexmedetomidine and Cognitive Reserve
Status: Enrolling
Updated: 3/22/2018
Englewood Hospital and Medical Center
mi
from
Englewood, NJ
Click here to add this to my saved trials
Perioperative Cognitive Function - Dexmedetomidine and Cognitive Reserve
Perioperative Cognitive Function - Dexmedetomidine and Cognitive Reserve
Status: Enrolling
Updated:  3/22/2018
Cleveland Clinic
mi
from
Cleveland, OH
Perioperative Cognitive Function - Dexmedetomidine and Cognitive Reserve
Perioperative Cognitive Function - Dexmedetomidine and Cognitive Reserve
Status: Enrolling
Updated: 3/22/2018
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
Perioperative Cognitive Function - Dexmedetomidine and Cognitive Reserve
Perioperative Cognitive Function - Dexmedetomidine and Cognitive Reserve
Status: Enrolling
Updated:  3/22/2018
The University of Maryland
mi
from
College Park, MD
Perioperative Cognitive Function - Dexmedetomidine and Cognitive Reserve
Perioperative Cognitive Function - Dexmedetomidine and Cognitive Reserve
Status: Enrolling
Updated: 3/22/2018
The University of Maryland
mi
from
College Park, MD
Click here to add this to my saved trials
Perioperative Cognitive Function - Dexmedetomidine and Cognitive Reserve
Perioperative Cognitive Function - Dexmedetomidine and Cognitive Reserve
Status: Enrolling
Updated:  3/22/2018
The Mayo Clinic
mi
from
Rochester, MN
Perioperative Cognitive Function - Dexmedetomidine and Cognitive Reserve
Perioperative Cognitive Function - Dexmedetomidine and Cognitive Reserve
Status: Enrolling
Updated: 3/22/2018
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Perioperative Cognitive Function - Dexmedetomidine and Cognitive Reserve
Perioperative Cognitive Function - Dexmedetomidine and Cognitive Reserve
Status: Enrolling
Updated:  3/22/2018
St. Louis University
mi
from
Saint Louis, MO
Perioperative Cognitive Function - Dexmedetomidine and Cognitive Reserve
Perioperative Cognitive Function - Dexmedetomidine and Cognitive Reserve
Status: Enrolling
Updated: 3/22/2018
St. Louis University
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Perioperative Cognitive Function - Dexmedetomidine and Cognitive Reserve
Perioperative Cognitive Function - Dexmedetomidine and Cognitive Reserve
Status: Enrolling
Updated:  3/22/2018
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
Perioperative Cognitive Function - Dexmedetomidine and Cognitive Reserve
Perioperative Cognitive Function - Dexmedetomidine and Cognitive Reserve
Status: Enrolling
Updated: 3/22/2018
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
Click here to add this to my saved trials
Perioperative Cognitive Function - Dexmedetomidine and Cognitive Reserve
Perioperative Cognitive Function - Dexmedetomidine and Cognitive Reserve
Status: Enrolling
Updated:  3/22/2018
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Perioperative Cognitive Function - Dexmedetomidine and Cognitive Reserve
Perioperative Cognitive Function - Dexmedetomidine and Cognitive Reserve
Status: Enrolling
Updated: 3/22/2018
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Perioperative Cognitive Function - Dexmedetomidine and Cognitive Reserve
Perioperative Cognitive Function - Dexmedetomidine and Cognitive Reserve
Status: Enrolling
Updated:  3/22/2018
Ohio State University
mi
from
Columbus, OH
Perioperative Cognitive Function - Dexmedetomidine and Cognitive Reserve
Perioperative Cognitive Function - Dexmedetomidine and Cognitive Reserve
Status: Enrolling
Updated: 3/22/2018
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
Evaluating the Risk of Cognitive Impairment After Surgical and Transcatheter Aortic Valve Replacement
Proposal for Collection of Patient Data to Aid in Design of an Observational Study (i.e. Preparatory to Research) Evaluating Risk of Cognitive Impairment After Surgical and Transcatheter Valve Replacement.
Status: Enrolling
Updated:  3/22/2018
Minneapolis VA Health Care System
mi
from
Minneapolis, MN
Evaluating the Risk of Cognitive Impairment After Surgical and Transcatheter Aortic Valve Replacement
Proposal for Collection of Patient Data to Aid in Design of an Observational Study (i.e. Preparatory to Research) Evaluating Risk of Cognitive Impairment After Surgical and Transcatheter Valve Replacement.
Status: Enrolling
Updated: 3/22/2018
Minneapolis VA Health Care System
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome, Aged 11 To 17
A 10-Week, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome, Aged 11 To 17
Status: Enrolling
Updated:  3/23/2018
Road Runner Research
mi
from
San Antonio, TX
Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome, Aged 11 To 17
A 10-Week, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome, Aged 11 To 17
Status: Enrolling
Updated: 3/23/2018
Road Runner Research
mi
from
San Antonio, TX
Click here to add this to my saved trials
Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome, Aged 11 To 17
A 10-Week, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome, Aged 11 To 17
Status: Enrolling
Updated:  3/23/2018
NeuroScience, Inc.
mi
from
Herndon, VA
Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome, Aged 11 To 17
A 10-Week, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome, Aged 11 To 17
Status: Enrolling
Updated: 3/23/2018
NeuroScience, Inc.
mi
from
Herndon, VA
Click here to add this to my saved trials
Dopamine Receptor Imaging to Predict Response to Stimulant Therapy in Chronic TBI
Dopamine Receptor Imaging to Predict Response to Stimulant Therapy in Chronic TBI
Status: Enrolling
Updated:  3/27/2018
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Dopamine Receptor Imaging to Predict Response to Stimulant Therapy in Chronic TBI
Dopamine Receptor Imaging to Predict Response to Stimulant Therapy in Chronic TBI
Status: Enrolling
Updated: 3/27/2018
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Study of TAK-071 in Healthy Participants and Participants With Mild Cognitive Impairment/Mild Alzheimer Disease and Relative Bioavailability (BA) and Food Effect of TAK-071 in Healthy Participants
A Phase 1 Safety, Tolerability, and Pharmacokinetic Study of Escalating Single and Multiple Oral Doses of TAK-071 in Healthy Subjects and Subjects With Mild Cognitive Impairment/Mild Alzheimer Disease and Relative Bioavailability and Food Effect of TAK-071 in Healthy Subjects
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
mi
from
Glendale, CA
Study of TAK-071 in Healthy Participants and Participants With Mild Cognitive Impairment/Mild Alzheimer Disease and Relative Bioavailability (BA) and Food Effect of TAK-071 in Healthy Participants
A Phase 1 Safety, Tolerability, and Pharmacokinetic Study of Escalating Single and Multiple Oral Doses of TAK-071 in Healthy Subjects and Subjects With Mild Cognitive Impairment/Mild Alzheimer Disease and Relative Bioavailability and Food Effect of TAK-071 in Healthy Subjects
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
mi
from
Glendale, CA
Click here to add this to my saved trials
TAK-071 Scopolamine-Induced Cognitive Impairment Study
A Randomized, Double-Blind, Sponsor Unblinded, Placebo-Controlled, 5-Period Crossover, Phase 1b Study To Evaluate The Effects Of Single Oral Administration of TAK-071 On Scopolamine-Induced Cognitive Impairment In Healthy Subjects
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
mi
from
Glendale, CA
TAK-071 Scopolamine-Induced Cognitive Impairment Study
A Randomized, Double-Blind, Sponsor Unblinded, Placebo-Controlled, 5-Period Crossover, Phase 1b Study To Evaluate The Effects Of Single Oral Administration of TAK-071 On Scopolamine-Induced Cognitive Impairment In Healthy Subjects
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
mi
from
Glendale, CA
Click here to add this to my saved trials
Clinical Pharmacology of p38 MAP Kinase Inhibitor, VX-745, in Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild AD
A Randomized, Open-Label, Multiple Dose Clinical Pharmacology Study of Two Doses of a Selective p38 MAP Kinase Inhibitor, VX-745 in Patients With Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease (AD) or With Mild AD
Status: Enrolling
Updated:  4/2/2018
Parexel International
mi
from
Glendale, CA
Clinical Pharmacology of p38 MAP Kinase Inhibitor, VX-745, in Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild AD
A Randomized, Open-Label, Multiple Dose Clinical Pharmacology Study of Two Doses of a Selective p38 MAP Kinase Inhibitor, VX-745 in Patients With Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease (AD) or With Mild AD
Status: Enrolling
Updated: 4/2/2018
Parexel International
mi
from
Glendale, CA
Click here to add this to my saved trials
A Combined Training Program for Veterans With Amnestic Mild Cognitive Impairment
A Combined Training Program for Veterans With Amnestic Mild Cognitive Impairment
Status: Enrolling
Updated:  4/3/2018
VA Palo Alto Health Care System
mi
from
Palo Alto, CA
A Combined Training Program for Veterans With Amnestic Mild Cognitive Impairment
A Combined Training Program for Veterans With Amnestic Mild Cognitive Impairment
Status: Enrolling
Updated: 4/3/2018
VA Palo Alto Health Care System
mi
from
Palo Alto, CA
Click here to add this to my saved trials
CARDIA Brain MRI Substudy
Contribution of Diabetes and Its Causes to Signs of Brain Aging in a Young-to-Middle Age Cohort
Status: Enrolling
Updated:  4/4/2018
National Institute of Aging, Clinical Research Unit
mi
from
Baltimore, MD
CARDIA Brain MRI Substudy
Contribution of Diabetes and Its Causes to Signs of Brain Aging in a Young-to-Middle Age Cohort
Status: Enrolling
Updated: 4/4/2018
National Institute of Aging, Clinical Research Unit
mi
from
Baltimore, MD
Click here to add this to my saved trials
Testing the FLASHE Survey
Cognitive Testing of the Family Life, Activity, Sun, Health, and Eating (FLASHE) Survey
Status: Enrolling
Updated:  4/4/2018
National Cancer Institute , 9000 Rockville Pike
mi
from
Bethesda, MD
Testing the FLASHE Survey
Cognitive Testing of the Family Life, Activity, Sun, Health, and Eating (FLASHE) Survey
Status: Enrolling
Updated: 4/4/2018
National Cancer Institute , 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy
A Prospective Study of Cognitive Function During Chemotherapy for Front-Line Treatment of Ovarian, Primary Peritoneal or Fallopian Tube Cancer
Status: Enrolling
Updated:  4/11/2018
University of Colorado Cancer Center - Anschutz Cancer Pavilion
mi
from
Aurora, CO
Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy
A Prospective Study of Cognitive Function During Chemotherapy for Front-Line Treatment of Ovarian, Primary Peritoneal or Fallopian Tube Cancer
Status: Enrolling
Updated: 4/11/2018
University of Colorado Cancer Center - Anschutz Cancer Pavilion
mi
from
Aurora, CO
Click here to add this to my saved trials
Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy
A Prospective Study of Cognitive Function During Chemotherapy for Front-Line Treatment of Ovarian, Primary Peritoneal or Fallopian Tube Cancer
Status: Enrolling
Updated:  4/11/2018
Northeast Georgia Medical Center
mi
from
Gainesville, GA
Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy
A Prospective Study of Cognitive Function During Chemotherapy for Front-Line Treatment of Ovarian, Primary Peritoneal or Fallopian Tube Cancer
Status: Enrolling
Updated: 4/11/2018
Northeast Georgia Medical Center
mi
from
Gainesville, GA
Click here to add this to my saved trials
Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy
A Prospective Study of Cognitive Function During Chemotherapy for Front-Line Treatment of Ovarian, Primary Peritoneal or Fallopian Tube Cancer
Status: Enrolling
Updated:  4/11/2018
Michiana Hematology-Oncology
mi
from
Elkhart, IN
Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy
A Prospective Study of Cognitive Function During Chemotherapy for Front-Line Treatment of Ovarian, Primary Peritoneal or Fallopian Tube Cancer
Status: Enrolling
Updated: 4/11/2018
Michiana Hematology-Oncology
mi
from
Elkhart, IN
Click here to add this to my saved trials
Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy
A Prospective Study of Cognitive Function During Chemotherapy for Front-Line Treatment of Ovarian, Primary Peritoneal or Fallopian Tube Cancer
Status: Enrolling
Updated:  4/11/2018
Elkhart General Hospital
mi
from
Elkhart, IN
Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy
A Prospective Study of Cognitive Function During Chemotherapy for Front-Line Treatment of Ovarian, Primary Peritoneal or Fallopian Tube Cancer
Status: Enrolling
Updated: 4/11/2018
Elkhart General Hospital
mi
from
Elkhart, IN
Click here to add this to my saved trials
Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy
A Prospective Study of Cognitive Function During Chemotherapy for Front-Line Treatment of Ovarian, Primary Peritoneal or Fallopian Tube Cancer
Status: Enrolling
Updated:  4/11/2018
Elkhart Clinic, LLC
mi
from
Elkhart, IN
Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy
A Prospective Study of Cognitive Function During Chemotherapy for Front-Line Treatment of Ovarian, Primary Peritoneal or Fallopian Tube Cancer
Status: Enrolling
Updated: 4/11/2018
Elkhart Clinic, LLC
mi
from
Elkhart, IN
Click here to add this to my saved trials
Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy
A Prospective Study of Cognitive Function During Chemotherapy for Front-Line Treatment of Ovarian, Primary Peritoneal or Fallopian Tube Cancer
Status: Enrolling
Updated:  4/11/2018
Indiana University Melvin and Bren Simon Cancer Center
mi
from
Indianapolis, IN
Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy
A Prospective Study of Cognitive Function During Chemotherapy for Front-Line Treatment of Ovarian, Primary Peritoneal or Fallopian Tube Cancer
Status: Enrolling
Updated: 4/11/2018
Indiana University Melvin and Bren Simon Cancer Center
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy
A Prospective Study of Cognitive Function During Chemotherapy for Front-Line Treatment of Ovarian, Primary Peritoneal or Fallopian Tube Cancer
Status: Enrolling
Updated:  4/11/2018
Community Howard Regional Health
mi
from
Kokomo, IN
Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy
A Prospective Study of Cognitive Function During Chemotherapy for Front-Line Treatment of Ovarian, Primary Peritoneal or Fallopian Tube Cancer
Status: Enrolling
Updated: 4/11/2018
Community Howard Regional Health
mi
from
Kokomo, IN
Click here to add this to my saved trials
Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy
A Prospective Study of Cognitive Function During Chemotherapy for Front-Line Treatment of Ovarian, Primary Peritoneal or Fallopian Tube Cancer
Status: Enrolling
Updated:  4/11/2018
Michiana Hematology Oncology
mi
from
Plymouth, IN
Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy
A Prospective Study of Cognitive Function During Chemotherapy for Front-Line Treatment of Ovarian, Primary Peritoneal or Fallopian Tube Cancer
Status: Enrolling
Updated: 4/11/2018
Michiana Hematology Oncology
mi
from
Plymouth, IN
Click here to add this to my saved trials
Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy
A Prospective Study of Cognitive Function During Chemotherapy for Front-Line Treatment of Ovarian, Primary Peritoneal or Fallopian Tube Cancer
Status: Enrolling
Updated:  4/11/2018
Memorial Hospital of South Bend
mi
from
South Bend, IN
Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy
A Prospective Study of Cognitive Function During Chemotherapy for Front-Line Treatment of Ovarian, Primary Peritoneal or Fallopian Tube Cancer
Status: Enrolling
Updated: 4/11/2018
Memorial Hospital of South Bend
mi
from
South Bend, IN
Click here to add this to my saved trials
Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy
A Prospective Study of Cognitive Function During Chemotherapy for Front-Line Treatment of Ovarian, Primary Peritoneal or Fallopian Tube Cancer
Status: Enrolling
Updated:  4/11/2018
Michiana Hematology Oncology-PC Westville
mi
from
Westville, IN
Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy
A Prospective Study of Cognitive Function During Chemotherapy for Front-Line Treatment of Ovarian, Primary Peritoneal or Fallopian Tube Cancer
Status: Enrolling
Updated: 4/11/2018
Michiana Hematology Oncology-PC Westville
mi
from
Westville, IN
Click here to add this to my saved trials
Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy
A Prospective Study of Cognitive Function During Chemotherapy for Front-Line Treatment of Ovarian, Primary Peritoneal or Fallopian Tube Cancer
Status: Enrolling
Updated:  4/11/2018
Mercy Cancer Center - West Lakes
mi
from
Clive, IA
Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy
A Prospective Study of Cognitive Function During Chemotherapy for Front-Line Treatment of Ovarian, Primary Peritoneal or Fallopian Tube Cancer
Status: Enrolling
Updated: 4/11/2018
Mercy Cancer Center - West Lakes
mi
from
Clive, IA
Click here to add this to my saved trials
Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy
A Prospective Study of Cognitive Function During Chemotherapy for Front-Line Treatment of Ovarian, Primary Peritoneal or Fallopian Tube Cancer
Status: Enrolling
Updated:  4/11/2018
Methodist West Hospital
mi
from
West Des Moines, IA
Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy
A Prospective Study of Cognitive Function During Chemotherapy for Front-Line Treatment of Ovarian, Primary Peritoneal or Fallopian Tube Cancer
Status: Enrolling
Updated: 4/11/2018
Methodist West Hospital
mi
from
West Des Moines, IA
Click here to add this to my saved trials
Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy
A Prospective Study of Cognitive Function During Chemotherapy for Front-Line Treatment of Ovarian, Primary Peritoneal or Fallopian Tube Cancer
Status: Enrolling
Updated:  4/11/2018
Cancer Center of Kansas, PA - Chanute
mi
from
Chanute, KA
Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy
A Prospective Study of Cognitive Function During Chemotherapy for Front-Line Treatment of Ovarian, Primary Peritoneal or Fallopian Tube Cancer
Status: Enrolling
Updated: 4/11/2018
Cancer Center of Kansas, PA - Chanute
mi
from
Chanute, KA
Click here to add this to my saved trials
Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy
A Prospective Study of Cognitive Function During Chemotherapy for Front-Line Treatment of Ovarian, Primary Peritoneal or Fallopian Tube Cancer
Status: Enrolling
Updated:  4/11/2018
Cancer Center of Kansas, PA - Dodge City
mi
from
Dodge City, KA
Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy
A Prospective Study of Cognitive Function During Chemotherapy for Front-Line Treatment of Ovarian, Primary Peritoneal or Fallopian Tube Cancer
Status: Enrolling
Updated: 4/11/2018
Cancer Center of Kansas, PA - Dodge City
mi
from
Dodge City, KA
Click here to add this to my saved trials
Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy
A Prospective Study of Cognitive Function During Chemotherapy for Front-Line Treatment of Ovarian, Primary Peritoneal or Fallopian Tube Cancer
Status: Enrolling
Updated:  4/11/2018
Cancer Center of Kansas, PA - El Dorado
mi
from
El Dorado, KA
Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy
A Prospective Study of Cognitive Function During Chemotherapy for Front-Line Treatment of Ovarian, Primary Peritoneal or Fallopian Tube Cancer
Status: Enrolling
Updated: 4/11/2018
Cancer Center of Kansas, PA - El Dorado
mi
from
El Dorado, KA
Click here to add this to my saved trials
Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy
A Prospective Study of Cognitive Function During Chemotherapy for Front-Line Treatment of Ovarian, Primary Peritoneal or Fallopian Tube Cancer
Status: Enrolling
Updated:  4/11/2018
Cancer Center of Kansas - Fort Scott
mi
from
Fort Scott, KA
Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy
A Prospective Study of Cognitive Function During Chemotherapy for Front-Line Treatment of Ovarian, Primary Peritoneal or Fallopian Tube Cancer
Status: Enrolling
Updated: 4/11/2018
Cancer Center of Kansas - Fort Scott
mi
from
Fort Scott, KA
Click here to add this to my saved trials
Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy
A Prospective Study of Cognitive Function During Chemotherapy for Front-Line Treatment of Ovarian, Primary Peritoneal or Fallopian Tube Cancer
Status: Enrolling
Updated:  4/11/2018
Cancer Center of Kansas-Independence
mi
from
Independence, KA
Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy
A Prospective Study of Cognitive Function During Chemotherapy for Front-Line Treatment of Ovarian, Primary Peritoneal or Fallopian Tube Cancer
Status: Enrolling
Updated: 4/11/2018
Cancer Center of Kansas-Independence
mi
from
Independence, KA
Click here to add this to my saved trials
Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy
A Prospective Study of Cognitive Function During Chemotherapy for Front-Line Treatment of Ovarian, Primary Peritoneal or Fallopian Tube Cancer
Status: Enrolling
Updated:  4/11/2018
Cancer Center of Kansas, PA - Kingman
mi
from
Kingman, KA
Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy
A Prospective Study of Cognitive Function During Chemotherapy for Front-Line Treatment of Ovarian, Primary Peritoneal or Fallopian Tube Cancer
Status: Enrolling
Updated: 4/11/2018
Cancer Center of Kansas, PA - Kingman
mi
from
Kingman, KA
Click here to add this to my saved trials
Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy
A Prospective Study of Cognitive Function During Chemotherapy for Front-Line Treatment of Ovarian, Primary Peritoneal or Fallopian Tube Cancer
Status: Enrolling
Updated:  4/11/2018
Lawrence Memorial Hospital
mi
from
Lawrence, KA
Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy
A Prospective Study of Cognitive Function During Chemotherapy for Front-Line Treatment of Ovarian, Primary Peritoneal or Fallopian Tube Cancer
Status: Enrolling
Updated: 4/11/2018
Lawrence Memorial Hospital
mi
from
Lawrence, KA
Click here to add this to my saved trials
Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy
A Prospective Study of Cognitive Function During Chemotherapy for Front-Line Treatment of Ovarian, Primary Peritoneal or Fallopian Tube Cancer
Status: Enrolling
Updated:  4/11/2018
Cancer Center of Kansas, PA - Liberal
mi
from
Liberal, KA
Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy
A Prospective Study of Cognitive Function During Chemotherapy for Front-Line Treatment of Ovarian, Primary Peritoneal or Fallopian Tube Cancer
Status: Enrolling
Updated: 4/11/2018
Cancer Center of Kansas, PA - Liberal
mi
from
Liberal, KA
Click here to add this to my saved trials
Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy
A Prospective Study of Cognitive Function During Chemotherapy for Front-Line Treatment of Ovarian, Primary Peritoneal or Fallopian Tube Cancer
Status: Enrolling
Updated:  4/11/2018
Cancer Center of Kansas, PA - Newton
mi
from
Newton, KA
Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy
A Prospective Study of Cognitive Function During Chemotherapy for Front-Line Treatment of Ovarian, Primary Peritoneal or Fallopian Tube Cancer
Status: Enrolling
Updated: 4/11/2018
Cancer Center of Kansas, PA - Newton
mi
from
Newton, KA
Click here to add this to my saved trials
Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy
A Prospective Study of Cognitive Function During Chemotherapy for Front-Line Treatment of Ovarian, Primary Peritoneal or Fallopian Tube Cancer
Status: Enrolling
Updated:  4/11/2018
Cancer Center of Kansas, PA - Parsons
mi
from
Parsons, KA
Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy
A Prospective Study of Cognitive Function During Chemotherapy for Front-Line Treatment of Ovarian, Primary Peritoneal or Fallopian Tube Cancer
Status: Enrolling
Updated: 4/11/2018
Cancer Center of Kansas, PA - Parsons
mi
from
Parsons, KA
Click here to add this to my saved trials
Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy
A Prospective Study of Cognitive Function During Chemotherapy for Front-Line Treatment of Ovarian, Primary Peritoneal or Fallopian Tube Cancer
Status: Enrolling
Updated:  4/11/2018
Cancer Center of Kansas, PA - Pratt
mi
from
Pratt, KA
Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy
A Prospective Study of Cognitive Function During Chemotherapy for Front-Line Treatment of Ovarian, Primary Peritoneal or Fallopian Tube Cancer
Status: Enrolling
Updated: 4/11/2018
Cancer Center of Kansas, PA - Pratt
mi
from
Pratt, KA
Click here to add this to my saved trials
Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy
A Prospective Study of Cognitive Function During Chemotherapy for Front-Line Treatment of Ovarian, Primary Peritoneal or Fallopian Tube Cancer
Status: Enrolling
Updated:  4/11/2018
Cancer Center of Kansas, PA - Salina
mi
from
Salina, KA
Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy
A Prospective Study of Cognitive Function During Chemotherapy for Front-Line Treatment of Ovarian, Primary Peritoneal or Fallopian Tube Cancer
Status: Enrolling
Updated: 4/11/2018
Cancer Center of Kansas, PA - Salina
mi
from
Salina, KA
Click here to add this to my saved trials
Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy
A Prospective Study of Cognitive Function During Chemotherapy for Front-Line Treatment of Ovarian, Primary Peritoneal or Fallopian Tube Cancer
Status: Enrolling
Updated:  4/11/2018
Cancer Center of Kansas, PA - Wellington
mi
from
Wellington, KA
Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy
A Prospective Study of Cognitive Function During Chemotherapy for Front-Line Treatment of Ovarian, Primary Peritoneal or Fallopian Tube Cancer
Status: Enrolling
Updated: 4/11/2018
Cancer Center of Kansas, PA - Wellington
mi
from
Wellington, KA
Click here to add this to my saved trials
Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy
A Prospective Study of Cognitive Function During Chemotherapy for Front-Line Treatment of Ovarian, Primary Peritoneal or Fallopian Tube Cancer
Status: Enrolling
Updated:  4/11/2018
Cancer Center of Kansas-Wichita Medical Arts Tower
mi
from
Wichita, KA
Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy
A Prospective Study of Cognitive Function During Chemotherapy for Front-Line Treatment of Ovarian, Primary Peritoneal or Fallopian Tube Cancer
Status: Enrolling
Updated: 4/11/2018
Cancer Center of Kansas-Wichita Medical Arts Tower
mi
from
Wichita, KA
Click here to add this to my saved trials